Tag: vaccine efficacy

BUT WHY?! Kenya Has Zero Cases But U.S Pharmaceutical Firm To Start Vaccine Trial + WHO Issues Monkeypox Advisory to Kenya

Tina Marie (Ms. Cat)

Video via Wongel Zelalem

Tonix will test its monkeypox vaccine in Kenya next year, and no eyes on accelerated path at FDA

The study of Tonix Pharmaceuticals’ live virus vaccine will occur at Kenya Medical Research Institute, or KEMRI, in the East African country, the partners said Thursday. While Kenya has no reported cases of the virus that leads to painful lesions, the country is close to the Democratic Republic of the Congo, which had 163 cases as of July 27, according to a CDC tracker.

…

Tonix has been working on monkeypox and smallpox for close to a decade, Lederman said. The company’s vaccine, dubbed TNX-801, is traced back to a research collaboration with the Department of Cell Biology at the University of Alberta.

Related:

Read More »

Why America Doesn’t Trust the CDC

Tina Marie (Ms. Cat)

Why America Doesn’t Trust the CDC

Most remarkably, it didn’t seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study that concluded in February. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.

…

Public health officials are expected to recommend COVID vaccines for children under 5 as soon as June 21st, despite the fact that the vast majority of children already have natural immunity. In a recent Kaiser survey, only 18 percent of parents said they were eager to vaccinate their child in that age group.

Biden Administration Makes Available 10 Million Doses of COVID Vaccine for Kids Under 5 — Before FDA Authorizes Shot

Tina Marie (Ms. Cat)

The Biden administration today said it made available 10 million doses of COVID-19 vaccines for children under age 5 to states and healthcare workers with “millions more available in the coming weeks.”

Biden Administration Makes Available 10 Million Doses of COVID Vaccine for Kids Under 5 — Before FDA Authorizes Shot

H/T: The Most Revolutionary Act

This is probably the worst thing I have seen so far.

Tina Marie (Ms. Cat)

You can’t spell hypocrisy without psycho!

Unacceptable Jessica May 28, 2022

Please read this article recently published online in the Toronto Star and written by Health Reporter Megan Ogilvie and Staff Reporter May Warren. You can simply read my screenshots if you’ve been subjected to inflation. To summarize, one Torontonian Dr. Sun claims to have put HIS neck on the line by illegally and unethically injecting 500 infants (children <5) with COVID-19 products that are now proven entirely obsolete against Omicron, in order to protect them from Omicron. Sounds informed and up-to-date, doesn’t he?

This is probably the worst thing I have seen so far.

H/T: Unorthodox Truth

J&J pauses production of its Covid-19 vaccine despite persistent need 💰

Tina Marie (Ms. Cat)

J&J pauses production of its Covid-19 vaccine despite persistent need

The facility, in the Dutch city of Leiden, has instead been making an experimental but potentially more profitable vaccine to protect against an unrelated virus.

…

But poorer countries remain reliant on Johnson & Johnson’s vaccine, which does not require ultracold refrigeration. It has been shown to provide strong and long-lasting protection against severe disease across variants, including omicron, when given as a two-shot regimen. As a single shot, the vaccine is less expensive and relatively easy to give to hard-to-reach populations.

…

Unlike companies such as Pfizer and Moderna, which have reaped billions of dollars in profits, Johnson & Johnson did not find the COVID vaccine to be a big moneymaker.

….

Since production of the COVID vaccine was halted late last year, the Netherlands plant has been manufacturing an experimental vaccine against respiratory syncytial virus, or RSV, that will be used for a clinical trial in older adults in wealthy countries, a person familiar with the matter said. Even if it proves effective, the vaccine is not expected to become available for several years.